| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.37 | 7e-14 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.3 | 4e-09 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.32 | 6e-07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 2e-05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.28 | 3e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.26 | 5e-05 |